Events & Presentations

Past Events

March 16, 2022 at 8:50 AM EDT

CEO Dr. James McArthur and VP of Clinical Science Dr. Jane Larkindale to present abstract, “Unlocking the potential of oligonucleotide therapeutics for Duchenne muscular dystrophy through enhanced delivery”